Product Information
- N-(2-Aminophenyl)2-pyrazinecarboxamide
Applications BG45 acts as an HDAC class I inhibitor with selectvity for HDAC3. HDACs represent novel targets for anti-tumer drugs treating various cancers including multiple myeloma cancer.
References Minami, J. et al.: Leukemia, 28, 680 (2014); Pinder, J. et al.: Pinder, J. et al.: Tetrahedron. Lett., 55, 4853 (2014);
Chemical properties
Technical inquiry about: TR-B366500 BG45
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.